About

A Pioneering Real-World Intelligence Company Transforming Clinical Research and Healthcare.

We bridge the gap between clinical trials and real-world practice by combining vast data sets and sources with our proprietary advanced analytic and generative AI solutions to deliver real-world market intelligence.

Mission

to improve quality, diversity, and integration of information by using technology to bridge the gap between market research and clinical science across the healthcare industry using proprietary Generative AI solutions.

Vision

to make a difference in healthcare through advanced analytics and real-world intelligence.

Values

we operate modern day algorithms with our own proprietary Generative AI solutions on top of large data sources, to give you real world in-market intelligence.

From the CEO

I have always been interested in how to disrupt the system of basic and clinical medical research to achieve better outcomes for people afflicted with disease. For me, it started with building systems that incorporated biomarker discovery and patient selection strategies to better predict which patients would truly benefit from which therapies. The most critical part of clinical research is the end game; unfortunately, most drugs underperform once they are broadly launched into the market, resulting in less-than-optimal care.

The advent and ubiquitous nature of mobile technology now give us the opportunity to understand the patient experience. Our company was founded to seamlessly integrate clinical data with market research in real-time to quickly deliver higher-quality drugs to patients in need.

RespondHealth
Founder and CEO

Our Team

We are a multi-disciplinary team with a history of leadership in science, clinical research, advanced analytics, artificial intelligence, regulatory affairs, care delivery, and management.  We are proven in our 10+ years of building tech-enabled point-of-care clinical trials.

VICKI SEYFERT-MARGOLIS

Founder and CEO

Vicki brings extensive experience and network connections in regulatory science and policy, innovative clinical trial designs, immunology and infectious disease studies, and advanced data analytics.

TOM DELAY

Chief Business Officer

Banking professional, lawyer and entrepreneur with 25+ years of experience supporting the commercial acceleration of finance, tech and healthcare companies.

ED KIM

Chief Scientific Officer

Research scientist with interests in the areas of deep learning, neuromorphic systems, and multimodal machine learning.  His recent work is in the area of neuro-symbolic AI and hybrid systems that combine both symbolic and connectionist machine learning approaches.

RICH FOTY

Director, Epidemiology and Analytics

Epidemiologist and Translational Research Professional Specializing in Real-World Evidence (RWE) and turning vast electronic health datasets into actionable insights, championing data-driven health solutions.

SAMMI MENTIS

Director, Operations

Seasoned professional with over 20 years of experience in the clinical research space, specifically in client management, operations and logistics, and budget oversight.

ERIKA ALONSO

Brand Strategy | Trade Marketing

Marketing executive and entrepreneur with decades of cross-platform experience delivering transformative B2B2C solutions for large market leaders, emerging disruptors and companies who aspire to be both.

CARLEEN HAWN

Advisor

Business and financial journalist-turned entrepreneur with 15+ years of experience supporting the development and commercial acceleration of transformative healthcare companies.

APARNA NALAWADE

Director, Platform Services

IT professional, with 16+ yrs experience and extensive knowledge in implementation of full product and testing lifecycle, including business requirements, analysis, modeling, testing, deployment and change management. 

BEN SIEGLER

Full Stack Engineer

Professional software developer with expertise in API and enterprise application design. 

 

Vicki Seyfert-Margolis, Ph.D.

 

Dr. Seyfert-Margolis founded RespondHealth (previously known as My Own Med, Inc.) to disrupt incumbent methods of clinical trialing, new product trialing and patient registry development – all in service of her aim to deliver better health outcomes to those afflicted with disease, both in care settings and out in the real world, where patients live their best lives.

Prior to RespondHealth, Vicki served in the Obama Administration as Senior Advisor for Science Innovation and Policy in the Office of the Commissioner of the US Food and Drug Administration, where she oversaw the development and execution of an agency-wide strategic plan for regulatory science. In this capacity, Vicki worked with academic and industry leaders on myriad science, regulatory and policy initiatives, encompassing mobile technologies, innovation in drug development, and companion diagnostics. 

Previously, Vicki served as Chief Scientific Officer at the Immune Tolerance Network (ITN), a non-profit consortium of researchers seeking new treatments for diseases of the immune system, where she guided more than 20 leading-edge assay development and centralized laboratory facilities to GLP and CLIA compliance. Vicki also previously served as Director of the Office of Innovative Scientific Research Technologies at the National Institute of Allergy and Infectious Diseases within the National Institutes of Health,  where she focused on integrating emerging technologies with NIH’s existing immunology and infectious disease programs.  

 Over her career, Vicki has designed and implemented more than 35 innovative Phase II and registration clinical trials. She is the author of 31+ academic white papers and peer-reviewed research papers, and she is a frequent keynote speaker on the topics of regulatory and drug discovery trends and the transformative impacts of digital technology on healthcare.  

 Vicki completed her PhD in immunology at the University of Pennsylvania’s School of Medicine, and her post-doctoral fellowship work at Harvard University and the National Cancer Institute. Vicki serves as a Board Director for the EveryLife Foundation for Rare Diseases, and the Eureka Institute for Translational Medicine.

To learn more, see: Solutions – RespondHealth

TOM DELAY

Tom is Chief Executive Officer of Healthspottr Capital and Chief Operating Officer of Healthspottr LLC. For more than 25 years, Tom has leveraged his legal and banking background to support the growth and commercial success of innovative and established firms in the tech, financial services and healthcare industries.

Early in his career, Tom served as General Counsel and head of exotic debt (pre-Brady debt) for New Capital Markets, a DC-based hedge fund focused on privatization in Russia and Eastern Europe. He later helped launch the family office business for Wells Fargo and served as Senior Vice President at U.S. Trust, where he managed a $2.5 billion portfolio for several ultra-high net worth families in the Bay Area.

In tech, Tom held senior business development roles at startups including Bang Networks and BeNotified Software. He entered healthcare by co-founding iHealth Analytics, a comparative analytics and resource utilization platform that sought to bring the same state-of-the art operating efficiencies long-used in finance to healthcare providers and payers for the first time.

Tom joined Healthspottr as COO in 2013 and most recently launched Healthspottr Capital, which provides capital raising and M&A services to large and small firms. Tom is a senior advisor to several companies including Axenic Health Solutions, which offers a novel, long-lasting sanitizing and disinfecting solutions for retail and healthcare settings, Care Angel, an AI-based nurse assistance provider, AIMO, a German startup leveraging motion analysis and AI to detect injury, pain and anxiety, and RespondHealth.

Tom earned his B.A from University of Iowa and a J.D. from Kansas University School of Law with a focus on international law and the impact on contracting in the oil and gas industry in Russia and Eastern Europe.

Ed Kim, PhD

Dr. Edward Kim is an Associate Professor in the Department of Computer Science in the College of Computing and Informatics at Drexel University.  His research interests are in the areas of deep learning, neuromorphic systems, and multimodal machine learning.  His recent work is in the area of neuro-symbolic AI and hybrid systems that combine both symbolic and connectionist machine learning approaches. 

His work is broadly inspired by concepts in theoretical neuroscience that incorporate ideas not currently explored by feed-forward deep learning architectures. His collaborative work with the Intel Corporation explored energy efficient algorithms on neuromorphic hardware. In 2019, Ed received the National Science Foundation’s CAREER award for his work in neuro-inspired machine learning.  In 2021, he was awarded a DARPA grant to explore sparse efficient coding on ultrasound images.    

Dr. Kim holds a PhD in Computer Science from Lehigh University, an MSE / BSE from the University of Pennsylvania and has held visiting positions at the Los Alamos National Laboratory, Naval Research Laboratory, National Institutes of Health, and University of Delaware.

Rich Foty, PhD

Dr. Richard Foty holds both a PhD and a Master’s degree in epidemiology from the University of Toronto, complemented by an Honours BSc in Kinesiology and Health Science from York University.

Dr. Foty brings over two decades of rich experience in research, data analytics, population health, and the development of predictive models that anticipate health trends and outcomes. His tenure at SickKids Hospital demonstrated his profound capabilities in clinical research, while his decade-long teaching role at the University of Toronto highlighted his dedication to educational excellence.

As an Assistant Professor, Dr. Foty was instrumental in shaping and delivering the Masters program in Translational Research at the University of Toronto, aiming to bridge the gap between scientific discoveries and their practical application in improving human health. His expertise in translational research also extended internationally, where he has taught and collaborated with diverse global institutions, further enriching the scope and impact of his work.

Beyond academia, he has excelled in corporate and government settings, enhancing knowledge development and applying his epidemiological expertise in the pharmaceutical industry. Dr. Foty’s multidimensional expertise positions him as a pivotal asset to initiatives focused on leveraging knowledge for substantial health advancements.

Sammi Mentis

Sammi Mentis is the Director, Operations at RespondHealth, responsible for the day-to-day operations of the Company. More recently, she also took on the client operations management role, overseeing all client activities for ongoing projects. Previously she served as the Manager, Site Support and Logistics Management at CardioCore Labs, Inc., where she was responsible for all operational activities for global provisioning of ECG and Holter equipment to clinical sites, from project start-up phase through project closing.

Prior to that Sammi worked as a Finance Analyst at the Immune Tolerance Network (UCSF) within the Tolerance Assay and Data Analysis Group, managing the group’s $11M budget and creating and managing the individual clinical trial budgets.

Sammi has a BSc. Finance/Management Studies from University of Maryland University College

ERIKA ALONSO

Erika is Co-founder and Chief Storyteller of Stairwell D, an agency specializing in digital B2B founded in 2008. Under Erika’s leadership, Stairwell D’s clients have included Discovery Communications, NBCUniversal, and Admeld (Google).

Erika also served as Chief Marketing Officer for Piccing, Inc, where she led global marketing, and user-experience. In this role, Erika repositioned Piccing into a social shopping experience resulting in 204% YOY revenue growth, 12 million monthly active users, and won the “Bully Award for European Innovation” at the 2015 White Bull Summit among +500 startups. In addition, she has led the branding and marcomm strategies for such seminal companies and brands as AOL/TimeWarner, Luminant Worldwide (now Razorfish.)

Perhaps most influential, however, is her work at Apple, Inc, where Erika developed the story for Apple’s global mobile advertising platform, known as iAd. She translated this positioning into a strategic product roadmap for Apple, thought leadership keynotes, sales collateral and creative partnerships with Fortune 50 brands.

After years envisioning and delivering strategies for others, Erika turned to entrepreneurship. In 2018 she co-founded Witi (Wellness Insight Technologies, Inc.), developer of Kazu, a hardware and software ecosystem in the rapidly growing cannabis sector. Kazu’s patented solution offers consumers a safe, personalized experience with precision dosing, and guidance from it’s integrated touch screen. The IP is currently licensed and under development by pharmaceutical company Perrigo [NYSE:PRGO]  deployed over a hand-held, medical-grade nicotine cessation therapy (NRT) device.  

An accomplished artist, Erika’s illustrations include projects with Geffen Records for MTV Music Awards, album covers for Smashing Pumpkins and her digital fine art inspired couture fashion designer Vivienne Tam who integrated Erika’s “Psychedellic Buddha” in her Spring 2000 Resort Collection. 

Erika earned her BFA in Communication Design and Illustration from Parson’s School of Design where she has served as a guest lecturer in the discipline of “Conceptual Thinking.” Erika is a native Spanish speaker, loves playing Devil’s Advocate and often starts a conversation with “Hmmmm… What if?” 

CARLEEN HAWN

Carleen is co-founder and CEO of Healthspottr LLC, a strategic networking and consulting company dedicated to accelerating the transformation of U.S. healthcare through technology and business-model innovations. Carleen has served as CEO since its inception and leads both the consulting and conferencing practices. Healthspottr Consulting, provides advisory services focused on strategy, business development, market development, product development, talent acquisition and thought leadership. Healthspottr Media curates in-person and virtual convenings to help participants foster new ideas, new relationships, and opportunities for new business with one another.

Prior to Healthspottr, Carleen spent nearly two decades as an award-winning business journalist, most notably with Forbes, where she created the well-known Midas List, an index of leading venture capital dealmakers now in its 22nd year of publication. Carleen later served as West Coast Bureau Chief for Fast Company magazine. Her work has appeared in numerous magazines including WIRED, Business 2.0 and Health Affairs.

Carleen serves as a board director or advisor to several firms, including Newtopia (NEWU), a habit change platform serving individuals at risk of chronic diseases, and My Own Med, Inc.

Carleen earned a B.A. from Barnard College, her M.S. from Columbia’s Graduate School of Journalism and attended both Columbia Law School and Columbia Business School as a Knight-Bagehot Fellow.

Aparna Nalawade

With over 17 years of IT experience, Aparna brings extensive expertise across the entire software lifecycle, including business analysis, requirements gathering, testing, and deployment. 

Aparna’s domain expertise spans various industries, including Life Sciences, Healthcare, Enterprise Security, and E-Commerce. She is highly proficient in utilizing cutting-edge tools and technologies to streamline processes and drive successful project outcomes.

Aparna’s key strengths include managing stakeholder relationships, ensuring clear communication, and addressing complex business challenges effectively. She consistently strive to deliver high-quality, efficient solutions that meet client needs, while adhering to timelines and business objectives. Her diverse background in both technical and business domains enables me to bridge gaps between IT and business teams, ensuring alignment and successful project delivery.

Aparna holds a Master’s degree in Computer Management and completed the Post Graduate Program in Business Analysis (PGP-CBAP) from Purdue University. She is also a Certified Scrum Master (CSM), with a strong focus on agile methodologies and delivering impactful solutions.

Ben Siegler

Ben is our in-house software developer at RespondHealth, ensuring everything from website buttons to complex data pipelines work seamlessly. He is also tasked with helping translate client needs into scalable solutions. 

Before joining RespondHealth, Ben worked as a freelance IT consultant and course content creator at CodingNomads, where he originally learned to create enterprise software solutions.